Using optical guidance for sentinel node biopsy in vulvar cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of combining sentinel lymph node mapping with FDG-PET/CT imaging in women diagnosed with vulvar cancer, specifically those with tumors larger than 4 cm, multifocal tumors, or local recurrences. The observational approach aims to assess how effectively this technique can stage the cancer and potentially improve treatment outcomes. By utilizing advanced imaging techniques, the study seeks to enhance the accuracy of lymph node assessment in this patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with vulva cancer, tumor \> 4 cm, multifocal tumor, or local recurrences in vulva

Exclusion Criteria:

* Previous external irradiation of the vulva or groins
* Former sentinel node or inguinal lymphadenectomy in the relevant groin
* Known allergy to ICG or iodine
* Patient is in active treatment for other cancer and/or disseminated disease

Where it's running

• Copenhagen University Hospital
  Copenhagen, Denmark Recruiting

Study contacts

• Study coordinator: Ligita P Frøding
• Email: ligita.paskeviciute.froeding@regionh.dk
• Phone: +4522722972

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Carbon nanoparticle‑loaded iron for advanced solid tumors

  This test uses direct injections of a carbon nanoparticle‑loaded iron medicine (CNSI‑Fe) to see if it can shrink tumors in adults with advanced solid cancers who have no effective standard treatment options.

  Recruiting at 4 sites Phase 1/2 Sichuan Enray Pharmaceutical Sciences Company · Beijing, Beijing Municipality and 8 other locations · NCT07433283

• Using indocyanine green to find sentinel lymph nodes during mastectomy

  This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.

  Recruiting at 2 sites St. Antonius Hospital · Zwolle, Overijssel and 1 other locations · NCT07362485

• Pembrolizumab plus lenvatinib for vulvar cancer (MITO VULVA-01)

  This trial will test whether combining pembrolizumab with lenvatinib helps people with advanced, recurrent, or unresectable vulvar cancer.

  Recruiting Phase 2 National Cancer Institute, Naples · Naples · NCT07290894

• Fast detection of cancer in sentinel lymph nodes using a new NIR-II fluorescent probe.

  This test applies a new near-infrared (NIR-II) fluorescent probe to freshly removed sentinel lymph nodes to quickly tell adults with breast cancer whether the cancer has spread there.

  Recruiting Yunnan Cancer Hospital · Kunming, Yunnan · NCT07154563

• Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery

  This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.

  Recruiting at 7 sites St. Antonius Hospital · Alkmaar and 6 other locations · NCT07146295

• Two-point versus four-point cervical methylene blue injections for sentinel lymph node mapping in stage I endometrial cancer

  This test checks whether using four cervical methylene blue injections instead of the usual two helps surgeons find sentinel lymph nodes in people with newly diagnosed stage I endometrial cancer who are having surgery.

  Recruiting at 2 sites Dokuz Eylul University · Ankara and 1 other locations · NCT07040657

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.